Literature DB >> 2920368

Selection criteria for local excision with or without adjuvant radiation therapy for rectal cancer.

B D Minsky1, T Rich, A Recht, W Harvey, C Mies.   

Abstract

As an alternative to radical surgery, local excision with or without adjuvant pelvic radiation therapy has been used in selected patients with rectal cancer. To determine which clinical and pathologic features can predict the presence of positive lymph nodes (LN+), a retrospective review of 168 patients who underwent potentially curative surgery for rectosigmoid and rectal cancer was performed. By univariate analysis, tumor penetration, grade, and histology were significant predictive features. This was confirmed by logistic regression analysis. The incidence of LN+ increased with increasing tumor penetration (T1, 0%; T2, 28%; T3, 36%; T4, 53%; P = 0.04), grade of adenocarcinoma (well-differentiated, 0%; moderately differentiated, 30%; poorly differentiated, 50%; P = 0.07, [borderline significance]), and the presence of any colloid histology (pure adenocarcinoma, 30%; total colloid, 52%; P = 0.04). Using 2 X 2 contingency tables, the presence of blood vessel invasion (BVI), lymphatic vessel invasion (LVI), vascular invasion (VI), total colloid histology, and high grade further increased the incidence of LN+ with increasing tumor penetration. Regardless of tumor size, grade, histology, BVI, LVI, or VI, none of the nine patients with Stage T1 tumors or the seven with well-differentiated adenocarcinomas had LN+. For this group, local excision alone is recommended. The incidence of LN+ was greater than or equal to 19% in all other categories. For this group of patients, if there is no evidence of gross tumor in the pelvis, then a local excision plus adjuvant pelvic radiation may be an alternative to radical surgery.

Entities:  

Mesh:

Year:  1989        PMID: 2920368     DOI: 10.1002/1097-0142(19890401)63:7<1421::aid-cncr2820630732>3.0.co;2-h

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  23 in total

Review 1.  Treatment of stage II-III rectal cancer patients.

Authors:  Miranda B Kim; Theodore S Hong; Jennifer Y Wo
Journal:  Curr Oncol Rep       Date:  2014       Impact factor: 5.075

2.  Local treatment for rectal cancer.

Authors:  Daniel P Geisler
Journal:  Clin Colon Rectal Surg       Date:  2007-08

Review 3.  Endocavitary irradiation in the conservative treatment of adenocarcinoma of the low rectum.

Authors:  J Papillon; P Berard
Journal:  World J Surg       Date:  1992 May-Jun       Impact factor: 3.352

4.  Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision?

Authors:  R Hughes; R Glynne-Jones; J Grainger; P Richman; A Makris; M Harrison; R Ashford; R A Harrison; J I Livingstone; P J McDonald; J Meyrick Thomas; I C Mitchell; J M A Northover; R Phillips; M Wallace; A Windsor; J R Novell
Journal:  Int J Colorectal Dis       Date:  2005-04-30       Impact factor: 2.571

5.  Local excision of T2 and T3 rectal cancers after downstaging chemoradiation.

Authors:  C J Kim; T J Yeatman; D Coppola; A Trotti; B Williams; J S Barthel; W Dinwoodie; R C Karl; J Marcet
Journal:  Ann Surg       Date:  2001-09       Impact factor: 12.969

6.  Assessment of remaining tumour involved lymph nodes with MRI in patients with complete luminal response after neoadjuvant treatment of rectal cancer.

Authors:  Per Loftås; Margrét Sturludóttir; Olof Hallböök; Karin Almlöv; Gunnar Arbman; Lennart Blomqvist
Journal:  Br J Radiol       Date:  2018-05-10       Impact factor: 3.039

7.  Transanal endoscopic microsurgery and radical surgery for T1 and T2 rectal cancer.

Authors:  W Lee; D Lee; S Choi; H Chun
Journal:  Surg Endosc       Date:  2003-05-13       Impact factor: 4.584

8.  Long-term results of transanal excision after neoadjuvant chemoradiation for T2 and T3 adenocarcinomas of the rectum.

Authors:  Rajesh M Nair; Erin M Siegel; Dung-Tsa Chen; William J Fulp; Timothy J Yeatman; Mokenge P Malafa; Jorge Marcet; David Shibata
Journal:  J Gastrointest Surg       Date:  2008-08-15       Impact factor: 3.452

9.  Transanal local excision for preoperative concurrent chemoradiation therapy for distal rectal cancer in selected patients.

Authors:  Chimin Park; Wooyong Lee; Sangah Han; Seonghyeon Yun; Ho-Kyung Chun
Journal:  Surg Today       Date:  2007-11-26       Impact factor: 2.549

Review 10.  Sphincter preservation in rectal cancer.

Authors:  C G Willett
Journal:  Curr Treat Options Oncol       Date:  2000-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.